Olema Pharmaceuticals, Inc.
OLMA
$27.65
$0.501.84%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.24% | -29.80% | -29.75% | -33.95% | -27.71% |
| Total Depreciation and Amortization | 14.79% | 30.83% | 18.63% | 4.24% | -5.44% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.26% | 19.67% | 28.54% | 18.46% | -15.46% |
| Change in Net Operating Assets | -93.64% | -101.56% | -4,802.42% | 1,655.86% | 375.81% |
| Cash from Operations | -39.50% | -37.81% | -43.76% | -24.63% | -13.63% |
| Capital Expenditure | 100.00% | 100.00% | 96.08% | -- | 8.09% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -995.56% | 2.31% | -90.32% | -1,819.16% | -123.16% |
| Cash from Investing | -978.17% | 2.48% | -89.90% | -1,827.97% | -123.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 909.56% | 61.87% | 87.60% | 106.49% | -81.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17,683.78% | -7,738.55% | -3,822.89% | -- | 130.83% |
| Cash from Financing | 866.59% | 55.61% | 83.23% | 101.49% | -81.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.23% | 296.95% | 335.07% | 58.22% | -189.97% |